This topic contains a solution. Click here to go to the answer

Author Question: Which of the following takes the longest to develop in a burn patient? a. hypothermia b. airway ... (Read 30 times)

bb

  • Hero Member
  • *****
  • Posts: 544
Which of the following takes the longest to develop in a burn patient?
 
  a. hypothermia
  b. airway compromise
  c. burn shock
  d. swelling and edema

Question 2

This condition is seen in the deeper areas of partial-thickness burns and is helped by good burn care and fluid resuscitation:
 
  a. zone of hyperemia
  b. zone of coagulation
  c. zone of stasis
  d. zone of necrosis



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

dudman123

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

C

Answer to Question 2

C




bb

  • Member
  • Posts: 544
Reply 2 on: Jul 2, 2018
Excellent


lindahyatt42

  • Member
  • Posts: 322
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

More than 50% of American adults have oral herpes, which is commonly known as "cold sores" or "fever blisters." The herpes virus can be active on the skin surface without showing any signs or causing any symptoms.

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

Of the estimated 2 million heroin users in the United States, 600,000–800,000 are considered hardcore addicts. Heroin addiction is considered to be one of the hardest addictions to recover from.

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library